LGND NASDAQ
Ligand Pharmaceuticals Incorporated
1W: +1.5%
1M: -2.1%
3M: +20.8%
YTD: +16.9%
1Y: +111.8%
3Y: +188.0%
5Y: +175.0%
$229.33
+7.15 (+3.22%)
Weekly Expected Move ±7.0%
$183
$198
$213
$228
$243
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$274M
Revenue
+51.2% YoY
$154M
Net Income
+215.8% YoY
$123M
Free Cash Flow
+246.4% YoY
96.0%
Gross Margin
33.6%
Op. Margin
-25.8%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE16.6%
ROA12.3%
ROIC11.4%
Valuation
P/E29.7
P/B4.6
EV/EBITDA14.5
Leverage
Debt/Equity0.44
Current Ratio22.23
Interest Cov.197.5x
Quality Scores
Piotroski F7/9
Altman Z6.20
Beneish M-2.03